Sann-Joong-Kuey-Jian-Tang can inhibit human breast cancer cells through dural-blocking both the Ras/Raf/MEK/ERK and Ras/PI3K/Akt/mTOR pathways

被引：0
|
作者：
Su, Chin Cheng
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2185
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Tanshinone IIA can decrease growth factor receptors expression and dural-block both Ras/Raf/MEK/ERK and Ras/PI3K/Akt/mTOR pathways to inhibit human breast cancer BT-20 cells
    Su, Chin Cheng
    CANCER RESEARCH, 2017, 77
  • [2] Sann-Joong-Kuey-Jian-Tang could inhibit human pancreatic carcinoma BxPC-3 cells through inducing autophagy
    Cheng, S. Chin
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S600 - S600
  • [3] Tanshinone IIA can inhibit MiaPaCa-2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways
    Su, Chin-Cheng
    ONCOLOGY REPORTS, 2018, 40 (05) : 3102 - 3111
  • [4] Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
    Saini, Kamal S.
    Loi, Sherene
    de Azambuja, Evandro
    Metzger-Filho, Otto
    Saini, Monika Lamba
    Ignatiadis, Michail
    Dancey, Janet E.
    Piccart-Gebhart, Martine J.
    CANCER TREATMENT REVIEWS, 2013, 39 (08) : 935 - 946
  • [5] Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
    Chappell, William H.
    Steelman, Linda S.
    Long, Jacquelyn M.
    Kempf, Ruth C.
    Abrams, Stephen L.
    Franklin, Richard A.
    Baesecke, Joerg
    Stivala, Franca
    Donia, Marco
    Fagone, Paolo
    Malaponte, Graziella
    Mazzarino, Maria C.
    Nicoletti, Ferdinando
    Libra, Massimo
    Maksimovic-Ivanic, Danijela
    Mijatovic, Sanja
    Montalto, Giuseppe
    Cervello, Melchiorre
    Laidler, Piotr
    Milella, Michele
    Tafuri, Agostino
    Bonati, Antonio
    Evangelisti, Camilla
    Cocco, Lucio
    Martelli, Alberto M.
    McCubrey, James A.
    ONCOTARGET, 2011, 2 (03) : 135 - 164
  • [6] Tanshinone IIA can inhibit human pancreatic carcinoma BxPC3 cells through decreasing the protein expressions of IGFR, EGFR, VEGFR and blocking both Ras/Raf/MEK/ERK and Ras/PI3K/AKT/mTOR pathway in vitro and in vivo
    Su, C. C.
    ANNALS OF ONCOLOGY, 2016, 27 : 7 - 7
  • [7] Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
    Qingfang Li
    Zhihui Li
    Ting Luo
    Huashan Shi
    Molecular Biomedicine, 3
  • [8] Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
    Li, Qingfang
    Li, Zhihui
    Luo, Ting
    Shi, Huashan
    MOLECULAR BIOMEDICINE, 2022, 3 (01):
  • [9] PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives
    Asati, Vivek
    Mahapatra, Debarshi Kar
    Bharti, Sanjay Kumar
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 : 314 - 341
  • [10] The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
    De Luca, Antonella
    Maiello, Monica R.
    D'Alessio, Amelia
    Pergameno, Maria
    Normanno, Nicola
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 : S17 - S27
12345